Work

Malignant peritoneal mesothelioma (MPM) who responded to rechallenge with cisplatin and pemetrexed with current literature review

Year: 2013

Type: article

Abstract: Peritoneal mesothelioma is an aggressive malignancy which is indeed very rare. Due to rarity, experience among many physicians surrounding the treatment of peritoneal mesothelioma is limited. Recently, we have received a patient who was initially treated palliatively with a combination of pemetrexd and cisplatin showing good response. On progression of his disease, he was again treated with the same drugs. This is not the strategy commonly used. We consider rechallenging cisplatin and pemetrexd to such patients who respond for the first time.

Source: BMJ Case Reports

DOI: 10.1136/bcr-2012-007786

Authors: Shahid Nazir Gilani, Rebecca Gridley, Gemma Searle, Apurna Jegannathen

Institutions: University Hospitals of North Midlands NHS Trust, Royal Stoke University Hospital

Language: English

Topic: Intraperitoneal and Appendiceal Malignancies

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: bronze

OpenAlex ID: W2007997953